DEA Updates Year-End Review
This Bulletin is brought to you by AHLA’s Life Sciences Practice Group.
- January 13, 2021
- Lindsay P. Holmes , BakerHostetler
- Lee H. Rosebush , BakerHostetler
- Marc N. Wagner , BakerHostetler
In a flurry of activity in the last months of 2020, the Drug Enforcement Administration (DEA) issued three updates to further the mission of DEA’s Diversion Control Division―to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources while ensuring an adequate and uninterrupted supply for legitimate medical, commercial, and scientific needs. These three developments include an update to the DEA Pharmacist’s Manual, a notice of proposed rulemaking (NPRM) for emergency medical services agencies, and an NPRM for suspicious order monitoring.
You must be logged in to access this content.